206
Participants
Start Date
June 1, 2025
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2028
Ambulatory care
Patients with Hepato cellular carcinoma (HCC) treated by chemo-embolization (CEH) or radioembolization (REH) are managed on an outpatient basis: hospitalization in an outpatient unit, followed by systematic telephone and on-demand nursing follow-up for 48 hours for REH and 72 hours for CEH. A dedicated re-hospitalization circuit has also been set up in the event of complications.
Conventional inpatient care
Patients with Hepato cellular carcinoma (HCC) treated by chemo-embolization (CEH) or radioembolization (REH) are managed on an inpatient basis: conventional hospitalization.
University hospital of Besançon, Besançon
University hospital of Brest, Brest
Univesity hospital of Bordeaux, Pessac
University hospital of Montpellier, Montpellier
University hospital of Grenoble-Alpes, La Tronche
Nantes, Nantes
University hospital of Angers, Angers
University hospital of Clermont-Ferrand, Clermont-Ferrand
Hospital of Pitié-Salpétrière (AP-HP), Paris
Hospital of Cochin (AP-HP), Paris
University hospital of Amiens, Amiens
Hospital of Vendée, La Roche-sur-Yon
Hospital of Beaujon (AP-HP), Clichy
Institut Gustave Roussy (IGR), Villejuif
Hospital of Avicennes (AP-HP), Bobigny
University hospital of Nice, Nice
Université Paris Cité
OTHER
University Hospital, Angers
OTHER_GOV